Hypertonic thermal solutions as a putative strategy for respiratory biofilm disruption
Authors:
- Marilina FalconeMarilina Falcone
- Laura PietrangeloLaura Pietrangelo
- Antonio GuarnieriAntonio Guarnieri
- Natasha BrancazioNatasha Brancazio
- Noemi VendittiNoemi Venditti
- Maria Di NaroMaria Di Naro
- Giulio Petronio PetronioGiulio Petronio Petronio
- Roberto Di MarcoRoberto Di Marco
- Attilio VarricchioAttilio Varricchio
Open Access
- 1 January 2026
- journal article
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 21 (1)
Abstract
Objectives: Upper respiratory tract infections pose a significant challenge for healthcare systems worldwide. Forming biofilms-complex polymicrobial communities encased in an exopolymer matrix plays a pivotal role in the persistence of these infections, contributing to enhanced resistance against conventional treatments and host immune responses. Consequently, developing innovative strategies to disrupt biofilms has become a therapeutic imperative.This study investigated the in vitro efficacy of a hypertonic solution of salsobromoiodic thermal water, in mitigating biofilm formation by key upper respiratory tract pathogens. Methods: Biofilm formation by Staphylococcus aureus , Moraxella catarrhalis , Haemophilus influenzae , Streptococcus pneumoniae , Candida albicans , Candida parapsilosis , and Candida tropicalis was assessed using the MBEC Assay ® system. The effects of the hypertonic salsobromoiodic thermal water solution were compared with standard saline (0.9 % NaCl). Results: A significant, concentration-dependent reduction in biofilm biomass was observed in all tested microorganisms when treated with the hypertonic solution. This effect was also evident in polymicrobial biofilms, indicating a broad and consistent antibiofilm potential. Conclusions: The hypertonic solution of salsobromoiodic thermal water demonstrated notable in vitro activity against biofilm formation by major upper respiratory tract pathogens. These findings highlight its potential as novel therapeutic approach for managing biofilm-associated respiratory infections and enhancing conventional antimicrobial treatments effectiveness.Keywords
This publication has 105 references indexed in Scilit:
- Haemophilus influenzae Forms Biofilms on Airway EpitheliaAmerican Journal of Respiratory and Critical Care Medicine, 2006
- The Efficacy of Hypertonic Saline Nasal Irrigation for Chronic Sinonasal SymptomsOtolaryngology–Head and Neck Surgery, 2005
- Nasal Mycology of Chronic RhinosinusitisAmerican Journal of Rhinology, 2005
- Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surfaceLetters in Applied Microbiology, 2004
- Diffusion in BiofilmsJournal of Bacteriology, 2003
- Contributions of Antibiotic Penetration, Oxygen Limitation, and Low Metabolic Activity to Tolerance of Pseudomonas aeruginosa Biofilms to Ciprofloxacin and TobramycinAntimicrobial Agents and Chemotherapy, 2003
- A modified microtiter-plate test for quantification of staphylococcal biofilm formationJournal of Microbiological Methods, 2000
- The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial BiofilmsJournal of Clinical Microbiology, 1999
- Antiseptics and Disinfectants: Activity, Action, and ResistanceClinical Microbiology Reviews, 1999
- [Treatment of chronic inflammation of the upper respiratory airways by inhalation thermal therapy with sulfur-sulfate-bicarbonate- carbonate-alkaline earth mineral water: a study of nasal cytology].1996